A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov
Description
INTRODUCTION: The global spread of COVID-19 has prompted the development of vaccines. A recombinant adenovirus type-5 vectored COVID-19 vaccine (Ad5-nCoV) developed by Chinese scientists has been authorized for use as a prime and booster dose in
